statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Apyx Medical Corporation (NASDAQ:APYX) (the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that financial...

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024

Apyx Medical Corporation (NASDAQ:APYX) (the Apyx Medical; Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, is pleased to announce...

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion Users Summit

In a report released today, Matt Hewitt from Craig-Hallum assigned a Buy rating to Apyx Medical (APYX Research Report). The company's shares clos...

Craig-Hallum Releases a Buy Rating on Apyx Medical (APYX)

Regenicin (OTCMKTS:RGIN - Get Free Report) and Apyx Medical (NASDAQ:APYX - Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two...

Head-To-Head Analysis: Regenicin (OTCMKTS:RGIN) & Apyx Medical (NASDAQ:APYX)

Q4 2023 Apyx Medical Corp Earnings Call Transcript

Apyx Medical Corporation (NASDAQ:APYX) (Apyx Medical; the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today reported...

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript...

Apyx Medical Corporation (APYX) Q4 2023 Earnings Call Transcript

Apyx Medical's Earnings: A Preview

Apyx Medical Corporation to Release Fourth Quarter and Fiscal Year 2023 Financial Results on March 21, 2024

Apyx Medical Corporation (Nasdaq: APYX) (Apyx Medical; the Company), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion, today announced that...

Apyx Medical Corporation Announces Renuvion to be Featured in Educational Sessions at the American Academy of Cosmetic Surgery (AACS) Scientific Meeting

Apyx Medical Corp. operates as an energy-based medical technology company. The firm engages in developing, manufacturing, and marketing a range of electrosurgical products and technologies, as well as related medical products used the offices of doctors, surgery centers, and hospitals worldwide. It operates through the following segments: Advanced Energy and Original Equipment Manufacture (OME). The company was founded by Andrew Makrides in 1978 and is headquartered in Clearwater, FL.

Volume	60,709.00
52-Wk High	$7.97
52-Wk Low	$1.21

Period	Estimated	Reported	Surprise	Result
Q1'24	-$0.22	--	--	N/A
Q4'23	-$0.18	-$0.28	-57.30%	MISSED
Q3'23	-$0.11	-$0.13	-14.04%	MISSED
Q2'23	-$0.07	-$0.03	57.14%	BEAT
Q1'23	-$0.14	-$0.10	25.93%	BEAT

APYX Apyx Medical Corp

About

Feed

News

Sentiment

Earnings

Fundamentals